Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-15

FDA Approved: MIRTAZAPINE — Supplemental Application (Aurolife Pharma LLC)

View source ↗

Summary

FDA granted a supplemental approval to Aurolife Pharma LLC for a generic form of mirtazapine, authorizing continued supply of the antidepressant product under a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • mirtazapine (mirtazapine)

Snippet

SUPPL AP for MIRTAZAPINE (MIRTAZAPINE)